[Federal Register Volume 79, Number 37 (Tuesday, February 25, 2014)]
[Notices]
[Pages 10527-10528]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-04021]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day 14-0004]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Leroy Richardson, 1600 Clifton Road NE., MS-D74,
Atlanta, Georgia 30333; comments may also be sent by email to
[email protected].
Comments are invited on (a) whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have a practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarify of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of information technology. Written comments
should be received within 60 days of this notice.
Proposed Project
National Disease Surveillance Program II. Disease Summaries (0920-
0004 Exp. 8/31/2014)--Revision--National Center for Immunization and
Respiratory Diseases, Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC requests a three year approval for a Revision of the National
Disease Surveillance Program II. Disease Summaries information
collection.
Proposed revisions include shifting information collection
management responsibilities to the National Center for Immunization and
Respiratory Diseases (NCIRD) and consolidating various forms to reflect
more current technology trends. Also, CDC requests the use of the
following new Influenza forms to enhance surveillance and assist in
understanding the complexities of these newer viruses: Human Infection
with Novel Influenza A Virus Severe Outcomes; Human Infection with
Novel Influenza A Virus with Suspected Avian Source; and Antiviral
Resistant Influenza Infection Case Report Form.
Due to the uncertainty regarding MERS-CoV and its threat to human
health, CDC also has a need to use a Middle East Respiratory Syndrome
Coronavirus (MERS-CoV) [Patient Under Investigation] form. Use of an
Adenovirus Typing Report Form and discontinuing the use of the Harmful
Algal Bloom-related Illness form is also requested. The Adenovirus
Typing Report Form allows for a passive surveillance mechanism that
collects adenovirus typing data to enhance adenovirus circulation data
already collected by the National Respiratory and Enteric Virus
Surveillance System (NREVSS).
The methodology for reporting varies depending on the occurrence,
modes of transmission, infectious agents, and epidemiologic measures.
There is no cost to respondents other than their time.
The total estimated annualized burden hours are 31,921.
Table 1--Estimated Annualized Burden Hours and Costs
----------------------------------------------------------------------------------------------------------------
Type of respondents state epidemiologists Number of Average burden
------------------------------------------------- Number of responses per per response Total burden
Form name respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Foodborne Outbreak Form (CDC 52.13)............. 54 32 20/60 576
Influenza virus (Internet; year round) (CDC 35 52 10/60 303
55.31).........................................
-Influenza virus (electronic, year round) 49 52 5/60 212
(PHLIP)........................................
-Influenza virus (electronic, year round) (PHIN- 3 52 5/60 13
MS)............................................
U.S. WHO Collaborating Laboratories Influenza 87 1 10/60 15
Testing Methods Assessment (CDC 55.31A)........
Weekly Influenza-like Illness (year round) (CDC 1,800 52 10/60 15,600
55.20).........................................
Daily Influenza-like illness (year round)....... 75 365 10/60 4,563
[[Page 10528]]
Influenza-Associated Pediatric Death Case Report 57 2 30/60 57
Form...........................................
Novel Influenza A Virus Case Screening Form..... 57 1 15/60 14
Novel Influenza A Virus Infection Contact 57 1 30/60 29
Tracing Form...................................
Human Infection with Novel Influenza A Virus 57 6 30/60 171
Case Report Form...............................
Novel and Pandemic Influenza A Virus Case Status 57 1 15/60 14
Summary........................................
Human Infection with Novel Influenza A Virus 57 1 1.5 86
Severe Outcomes................................
Human Infection with Novel Influenza A Virus 57 1 30/60 29
with Suspected Avian Source....................
122 CMRS--City health officers or vital 58 365 12/60 4,234
statistics registrars (daily)..................
122 CMRS--City health officers or vital 122 52 12/60 1,269
statistics registrars (weekly).................
Aggregate Hospitalization and Death Reporting 56 52 10/60 485
Activity Weekly Report Form....................
Antiviral Resistant Influenza Infection Case 57 3 30/60 86
Report Form....................................
National Enterovirus Surveillance Report: (CDC 25 12 15/60 75
55.9) (electronic).............................
National Respiratory & Enteric Virus 300 52 15/60 3,900
Surveillance System (NREVSS) (CDC 55.83A, B,
NREVSS Lab Assessment Form, D) (electronic)....
Adenovirus Typing Report Form................... 25 12 15/60 75
Middle East Respiratory Syndrome Coronavirus 57 3 25/60 71
(MERS) Patient Under Investigation (PUI) Form..
Suspected Viral Gastroenteritis (Calicivirus 20 5 15/60 25
surveillance)..................................
Waterborne Diseases Outbreak Form (CDC 52.12)... 57 1 20/60 19
---------------------------------------------------------------
Total................................... .............. .............. .............. 31,921
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-04021 Filed 2-24-14; 8:45 am]
BILLING CODE 4163-18-P